The problem with colorectal cancer screening kits

More than 10% of tests for colorectal cancer screening contained samples that could not be processed for labs.

November 17, 2023 Check out STAT+

Sponsored By

Adobe Colon cancer screening kits have a high rate of untestable samples More than 10% of the tests used for routine colorectal cancer screening contained samples that could not be processed by labs. By Deborah Balthazar Progress in childhood cancer has stalled for Blacks and Hispanics, report says Advances in childhood cancer have stalled for Black and Hispanic youth over the past two decades, opening a gap in U.S. death rates. By Associated Press STAT+ | Bristol wins U.S. approval for lung cancer drug targeting rare genetic mutation The drug was developed by a small biotech company, Turning Point Therapeutics, that was acquired by Bristol in June 2022. By Adam Feuerstein Adobe STAT+ | To get things done fast at FDA: 'Don't tell anybody,' cancer chief says The Food and Drug Administration's top cancer drug regulator doesn't always ask for permission before taking on big initiatives. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser